Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with su...
Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Background
Molecular breast imaging (MBI) performed with
99m
Tc sestamibi has been shown to be a valuable technique for the detection of breast cancer. Alternative radiotracers such as
99m
Tc maraciclatide may offer improved uptake in breast lesions. The purpose of this study was to compare relative performance of
99m
Tc sestam...
Alternative Titles
Full title
Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5237435
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5237435
Other Identifiers
ISSN
2191-219X
E-ISSN
2191-219X
DOI
10.1186/s13550-017-0255-6
